Novartis reported $122.91B in Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Amgen AMGN:US $ 59294M 98M
Astrazeneca AZN:US $ 96579M 3694M
AstraZeneca AZN:LN 7932612.74M 297425.43M
Biogen BIIB:US $ 25081.4M 1467M
Bristol Myers Squibb BMY:US $ 100357M 2677M
Canopy Growth Corp WEED:CN C$ 3.52B 2.1B
Catalent CTLT:US $ 10507M 185M
Corcept Therapeutics CORT:US $ 496.36M 28.24M
Eli Lilly And LLY:US $ 47063.6M 144.3M
Endo International Ordinary Shares ENDP:US $ 6362.26M 2084.95M
Gilead Sciences GILD:US $ 62870M 210M
Glaxosmithkline GSK:US $ 89045M 644M
GlaxoSmithKline GSK:LN 8904500M 64400M
Horizon Pharma HZNP:US $ 8853.47M 113.14M
JAZZ PHA JAZZ:US $ 11200.13M 568.78M
Lannett LCI:US $ 484.44M 87.87M
Novartis NOVN:VX SF 122910M 2308M
Pacira Pharmaceuticals PCRX:US $ 1733.99M 157.49M
Perrigo Ordinary Shares PRGO:US $ 10919.6M 530.1M
Phibro Animal Health PAHC:US $ 931.7M 15.52M
Prestige Brands PBH:US $ 3682.23M 11.55M
Supernus Pharmaceuticals SUPN:US $ 1694.97M 55.46M
Teva Pharmaceutical Industries TEVA:US $ 45932M 1127M
Valeant Pharmaceuticals VRX:CN $ 36261.71M 7171.71M
Zoetis ZTS:US $ 13770M 90M